Tetralogic Pharmaceuticals Corp (TLOG) financial statements (2021 and earlier)

Company profile

Business Address 343 PHOENIXVILLE PIKE
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2054
Cash and cash equivalents1513
Short-term investments541
Deferred costs 0
Other undisclosed current assets22
Total current assets:2256
Noncurrent Assets
Property, plant and equipment01
Intangible assets, net (including goodwill)4258
Goodwill 17
Intangible assets, net (excluding goodwill)4242
Deferred costs 1
Other noncurrent assets02
Total noncurrent assets:4262
TOTAL ASSETS:64118
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46
Accounts payable01
Accrued liabilities34
Employee-related liabilities 1
Interest and dividends payable 0
Derivative instruments and hedges, liabilities00
Other undisclosed current liabilities (2)
Total current liabilities:45
Noncurrent Liabilities
Long-term debt and lease obligation2829
Long-term debt, excluding current maturities2829
Liabilities, other than long-term debt1719
Deferred tax liabilities, net1717
Derivative instruments and hedges, liabilities02
Other undisclosed noncurrent liabilities2132
Total noncurrent liabilities:6680
Total liabilities:7085
Stockholders' equity
Stockholders' equity attributable to parent(6)33
Common stock00
Additional paid in capital170159
Accumulated other comprehensive loss(0)(0)
Accumulated deficit(176)(126)
Total stockholders' equity:(6)33
TOTAL LIABILITIES AND EQUITY:64118

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
Operating expenses(45)(34)
Operating loss:(45)(34)
Nonoperating income21
Investment income, nonoperating21
Interest and debt expense(7)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes0 
Net loss:(50)(36)
Other undisclosed net income (loss) attributable to parent(0)0
Net loss available to common stockholders, basic:(50)(36)
Other undisclosed net loss available to common stockholders, diluted(0)(0)
Net loss available to common stockholders, diluted:(50)(36)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
Net loss:(50)(36)
Comprehensive loss:(50)(36)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0
Comprehensive loss, net of tax, attributable to parent:(50)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: